• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

US Physicians' Views on the COVID-19 Response

Slideshow

A recent survey found US physicians have significant concerns about clinic precautions, government response, and testing availability.

In order to better understand physicians' views on the current coronavirus disease 2019 (COVID-19) response, Doximity-in partnership with Harvard Medical School and the RAND Corporation-surveyed 2617 US physicians via email between March 21-24, 2020. Respondents represented all major specialties and US states. Scroll through the slides below to find out how the physicians responded to 10 questions on medical supplies, testing availability, government response, and more.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone

Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone

April 22nd 2024
Article

Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

RSV Disease Severity Comparable to Unvaccinated COVID-19, Influenza: New Research / image credit older man in hospital ©auremar/stock.adobe.com

RSV Disease Severity Comparable to Unvaccinated COVID-19, Influenza: New Research

April 11th 2024
Article

In adults hospitalized with RSV, odds of severe outcomes, including death, were much higher than for those admitted for, but vaccinated against, COVID-19, flu.

Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns

Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns

October 25th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with American Academy of Family Physicians Board Chair Sterling Ransone, Jr, MD.

Moderna Next-Gen mRNA COVID-19 Vaccine Meets Primary Endpoints in NextCOVE Phase 3 Trial / image credit Moderna logo: ©desertsands/stock.adobe.com

Moderna Next-Gen mRNA COVID-19 Vaccine Meets Primary Endpoints in NextCOVE Phase 3 Trial

March 27th 2024
Article

The mRNA bivalent vaccine candidate produced a "more robust" immune response vs Spikevax and particularly in adults over the age of 65 years, said Moderna.

COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes for up to 1 Year, According to New Data / Image credit: ©Tsuboya/AdobeStock

COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes for up to 1 Year, According to New Data

March 21st 2024
Article

New research highlights another benefit of COVID-19 vaccination, reported researchers.

© 2024 MJH Life Sciences

All rights reserved.